Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management

J Am Geriatr Soc. 2021 Jul;69(7):1807-1810. doi: 10.1111/jgs.17142. Epub 2021 Apr 24.

Authors

Stephanie L Harrison¹, Asangaedem Akpan^{2

3}, Gregory Y H Lip^{1

4}

Affiliations

¹ Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
² Institute of Life Course and Medical Sciences & Liverpool University Hospital NHS FT, Liverpool, UK.
³ Institute of Health, University of Cumbria, Carlisle, UK.
⁴ Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

PMID: 33893638
DOI: 10.1111/jgs.17142

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / adverse effects
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Cognitive Dysfunction* / diagnosis
Frailty* / diagnosis
Humans
Mass Screening

Substances

Anticoagulants